help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woods, D.
Right arrow Articles by Montgomery, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, D.
Right arrow Articles by Montgomery, H.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 5 2200-2204
Copyright © 2001 by The Endocrine Society


Original Studies

Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density1

David Woods, Gladys Onambele, Roger Woledge, Dawn Skelton, Stuart Bruce, Steve E. Humphries and Hugh Montgomery

Department of Cardiovascular Genetics (D.W., S.E.H., H.M.), Rayne Institute, University College London, London WC1E 6JJ, United Kingdom; Institute of Human Performance (G.O., R.W., S.B.), University College London, Royal National Orthapaedic Hospital, Stanmore HA7 4LP, United Kingdom; and Department of Cellular and Integrate Biology (D.S.), Division of Biomedical Sciences, Imperial College School of Medicine at St. Mary’s, London W2 1PG, United Kingdom

Address all correspondence and requests for reprints to: Major David Woods, M.D., Department of Diabetes and Endocrinology, Freeman Hospital, Newcastle Upon Tyne NE7 709, United Kingdom.

Low bone mineral density (BMD) and muscle weakness are major risk factors for postmenopausal osteoporotic fracture. Hormone replacement therapy (HRT) reverses the menopausal decline in maximum voluntary force of the adductor pollicis and reduces serum angiotensin-I converting enzyme (ACE) levels. The insertion (I) allele of the ACE gene polymorphism is associated with lower ACE activity and improved muscle efficiency in response to physical training. Therefore, we examined whether the presence of the I allele in postmenopausal women would affect the muscle response to HRT. Those taking HRT showed a significant gain in normalized muscle maximum voluntary force slope, the rate of which was strongly influenced by ACE genotype (16.0 ± 1.53%, 14.3 ± 2.67%, and 7.76 ± 4.13%, mean ± SEM for II, ID, and DD genotype, respectively; P = 0.017 for gene effect, P = 0.004 for I allele effect). There was also a significant ACE gene effect in the response of BMD to HRT in Ward’s triangle (P = 0.03) and a significant I allele effect in the spine (P = 0.03), but not in the neck of femur or total hip. These data suggests that low ACE activity associated with the I allele confers an improved muscle and BMD response in postmenopausal women treated with HRT.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. L. Onambele-Pearson
HRT affects skeletal muscle contractile characteristics: a definitive answer?
J Appl Physiol, July 1, 2009; 107(1): 4 - 5.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. H. A. Ronkainen, V. Kovanen, M. Alen, E. Pollanen, E.-M. Palonen, C. Ankarberg-Lindgren, E. Hamalainen, U. Turpeinen, U. M. Kujala, J. Puolakka, et al.
Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs
J Appl Physiol, July 1, 2009; 107(1): 25 - 33.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. McCauley, S. S. Mastana, J. Hossack, M. MacDonald, and J. P. Folland
Human angiotensin-converting enzyme I/D and {alpha}-actinin 3 R577X genotypes and muscle functional and contractile properties
Exp Physiol, January 1, 2009; 94(1): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
I. McCarthy
The Physiology of Bone Blood Flow: A Review
J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 4 - 9.
[Abstract] [Full Text] [PDF]


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
S. M. Roth, J. M. Zmuda, J. A. Cauley, P. R. Shea, and R. E. Ferrell
Vitamin D Receptor Genotype Is Associated With Fat-Free Mass and Sarcopenia in Elderly Men
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2004; 59(1): B10 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Tiainen, S. Sipila, M. Alen, E. Heikkinen, J. Kaprio, M. Koskenvuo, A. Tolvanen, S. Pajala, and T. Rantanen
Heritability of maximal isometric muscle strength in older female twins
J Appl Physiol, January 1, 2004; 96(1): 173 - 180.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. M. Roth, E. J. Metter, M. R. Lee, B. F. Hurley, and R. E. Ferrell
C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women
J Appl Physiol, October 1, 2003; 95(4): 1425 - 1430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society